Gilead reports positive OS results for Trodelvy in TROPiCS-02 trial
The late-stage trial evaluated the Trop-2 directed antibody-drug conjugate in comparison to TPC chemotherapy in 543 patients having…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Sep 22
The late-stage trial evaluated the Trop-2 directed antibody-drug conjugate in comparison to TPC chemotherapy in 543 patients having…
07 Sep 22
Emergence Therapeutics has secured license to use the GlycoConnect, HydraSpace and exatecan-based SYNtecan E linker-payload technologies to develop…
05 Sep 22
Spesolimab, a monoclonal antibody that inhibits the activation of interleukin-36 (IL-36) signalling, is said to be the first…
02 Sep 22
"More than ever, shoppers are increasingly demanding breakfast cereals in innovative and delicious flavors that provide a multitude…
02 Sep 22
The acquisition will complement Novo Nordisk’s strategy to focus on haemoglobinopathies, a group of disorders characterised by abnormal…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
01 Sep 22
Pfizer and BioNTech’s bivalent Covid-19 vaccine is authorised as single booster dose for adults and adolescents aged 12…
01 Sep 22
The approval is based on the data from ASCEND and ASCEND-Peds trials, in which Xenpozyme showed improvement in…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
30 Aug 22
The EC approval is based on results from Phase 3 ASCEMBL trial, in which Scemblix nearly doubled the…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
30 Aug 22
Patients receiving treatment with cemdisiran experienced clinically significant decreases in their 24-hour urine protein to creatinine ratio when…
29 Aug 22
If approved, both Omicron BA.1-adapted and Omicron BA.4/BA.5-adapted bivalent vaccines will be commercially available in the European Union…